Recent supply chain bottlenecks of hospital gear shows why continued dependence on Asia is bad for pandemic preparedness. The Make PPE in America Act in the infrastructure law should remedy this in the years ahead, if Congress doesn’t open the doors to duty-free PPE and undercut the law’s intent.
Commerce banned more Chinese defense contractors from buying American computer hardware, other high-tech goods. Why can Vanguard and State Street still invest in them?
A look at the three largest bills recently circulating in Washington, including the recently passed infrastructure law, and how they’ve gone soft on forced labor. The opportunity presented itself to take the issue more seriously than just another round of studies in each bill mentioned here.
At this week’s Trade Subcommittee hearing at House Ways & Means, talk of changing de minimis rules for goods bought on line; forced labor; and a few diehards bring up TPP.
Congressional-Executive Commission on China heard from four witnesses on November 17 discussing what China’s new tech companies means to the U.S. both in terms of business rivalries abroad, and creeping surveillance by the CCP.
The House Committee on Transportation and Infrastructure expects supply constraints to last into early 2022. Rep. John Garamendi of California highlights “tremendous trade imbalances” as one reason for the bottlenecks, caused by a surge in demand for Asian made goods.
A House Energy and Commerce Committee hearing on clean energy technologies shows division among the parties, with one main agreement: the U.S. will lose out on this market if Washington allows for dependence on Asia for solar, wind and EV battery materials.
The Senate Finance Committee’s confirmation hearing for two trade specialists appointed by Biden shows an obvious rift with the Executive Branch over recent China trade decisions.
The U.S. China Business Council sent a letter to Treasury and the US Trade Representative to reduce tariffs ahead of Biden-Xi chat.
Free trade loses out to a bigger government role in securing domestic supply chains of critical medication.